Dr. Shiovitz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4835 Van Nuys Blvd
Ste 104
Sherman Oaks, CA 91403Phone+1 310-285-9421Fax+1 818-986-9716
Education & Training
- Cedars-Sinai Medical CenterResidency, Psychiatry, 1986 - 1987
- Cedars-Sinai Medical CenterResidency, Psychiatry, 1984 - 1985
- VA Greater Los Angeles Healthcare SystemInternship, Transitional Year, 1983 - 1984
- University of Michigan Medical SchoolClass of 1983
Certifications & Licensure
- CA State Medical License 1984 - 2026
- GA State Medical License 1995 - 2007
- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo Start of enrollment: 2013 Jul 01
- A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease Start of enrollment: 2016 Jun 01
Publications & Presentations
PubMed
- 66 citationsMitigating the Effects of Nonadherence in Clinical TrialsThomas M. Shiovitz, Earle Bain, David J. McCann, Phil Skolnick, Thomas P. Laughren
Journal of Clinical Pharmacology. 2016-09-01 - 164 citationsTargeting Prodromal Alzheimer Disease With Avagacestat: A Randomized Clinical TrialVladimir Coric, Stephen Salloway, Christopher H. van Dyck, Bruno Dubois, Niels Andreasen
JAMA Neurology. 2015-11-01 - 250 citationsA randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition.Edmund P. Harrigan, J.J. Miceli, R.J. Anziano, Watsky Eric Jacob, Karen R. Reeves
Journal of Clinical Psychopharmacology. 2004-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: